ConductScience.org, home

Paper30416846

Iron and magnetic: new research direction of the ferroptosis-based cancer therapy.

Wang S and 11 others. Am J Cancer Res, 2018. Cited by 102 papers, by iCite.

Cite this record

ConductScience Library. Iron and magnetic: new research direction of the ferroptosis-based cancer therapy. Papers, record 30416846. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30416846

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Iron and magnetic: new research direction of the ferroptosis-based cancer therapy.
PubMed
Journal
Am J Cancer Res
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
102
iCite
Relative citation ratio, by iCite
4.12
iCite
Revised in PubMed
2023-10-04
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang SShenghang
2Luo JJie
3Zhang ZZhihao
4Dong DDandan
5Shen YYing
6Fang YYanwen
7Hu LLijiang
8Liu MMengyu
9Dai CChengfu
10Peng SSonglin
11Fang ZZhicai
12Shang PPeng

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References80

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128223795Nanoparticle-based hyperthermia distinctly impacts production of ROS, expression of Ki-67, TOP2A, and TPX2, and induction of apoptosis in pancreatic cancer.Int J Nanomedicine2017https://conductscience.org/library/papers/28223795PubMed
227514700Ferroptosis is an autophagic cell death process.Cell Res2016https://conductscience.org/library/papers/27514700PubMed
318355723Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells.Chem Biol2008https://conductscience.org/library/papers/18355723PubMed
427287467Iron Oxide Nanoparticles Induce Autophagosome Accumulation through Multiple Mechanisms: Lysosome Impairment, Mitochondrial Damage, and ER Stress.Mol Pharm2016https://conductscience.org/library/papers/27287467PubMed
515456710Microenvironmental and cellular consequences of altered blood flow in tumours.Br J Radiol2003https://conductscience.org/library/papers/15456710PubMed
623102669MicroRNA and cancer.Mol Oncol2012https://conductscience.org/library/papers/23102669PubMed
716278235Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice.Hum Mol Genet2005https://conductscience.org/library/papers/16278235PubMed
825728673HSPB1 as a novel regulator of ferroptotic cancer cell death.Oncogene2015https://conductscience.org/library/papers/25728673PubMed
928453245External Magnetic Field-Enhanced Chemo-Photothermal Combination Tumor Therapy via Iron Oxide Nanoparticles.ACS Appl Mater Interfaces2017https://conductscience.org/library/papers/28453245PubMed
1018678913Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18678913PubMed
1126403645Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.Hepatology2016https://conductscience.org/library/papers/26403645PubMed
1225236395Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.Cell Death Differ2015https://conductscience.org/library/papers/25236395PubMed
1327184711Physical, Chemical, and Biological Structures based on ROS-Sensitive Moieties that are Able to Respond to Oxidative Microenvironments.Adv Mater2016https://conductscience.org/library/papers/27184711PubMed
1426379789Targeted Mesoporous Iron Oxide Nanoparticles-Encapsulated Perfluorohexane and a Hydrophobic Drug for Deep Tumor Penetration and Therapy.Theranostics2015https://conductscience.org/library/papers/26379789PubMed
1527668796Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth.Nat Nanotechnol2016https://conductscience.org/library/papers/27668796PubMed
1627441659Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells.Cell Death Dis2016https://conductscience.org/library/papers/27441659PubMed
1723740388Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes.Chem Soc Rev2013https://conductscience.org/library/papers/23740388PubMed
189708920Increased flux of free radicals in cells subjected to hyperthermia: detection by electron paramagnetic resonance spin trapping.FEBS Lett1998https://conductscience.org/library/papers/9708920PubMed
1923620667Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro.Int J Nanomedicine2013https://conductscience.org/library/papers/23620667PubMed
2015516961Why do cancers have high aerobic glycolysis?Nat Rev Cancer2004https://conductscience.org/library/papers/15516961PubMed

See all 80 referencesDownload CSV of references

Cited by79

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 102 citations.

PMIDTitleJournalYearIn PapersSource
42978988Magnetic nanoplatforms at the tumor redox interface: from catalytic ROS amplification to ferroptosis and multimodal cancer therapy.Front Oncol2026https://conductscience.org/library/papers/42978988PubMed
42825017Ferroptosis in metabolic dysfunction-associated steatotic liver disease.Front Immunol2026https://conductscience.org/library/papers/42825017PubMed
42803694Gestational Changes in Placental Iron Homeostasis are Associated With Ferroptosis-Associated Redox Signaling and Trophoblast Behavior.FASEB J2026https://conductscience.org/library/papers/42803694PubMed
42776293The SLC7A11 Thermostat: A Molecular Signaling Switch Between Ferroptosis and Disulfidptosis in Neurodegenerative Disease.Mol Neurobiol2026https://conductscience.org/library/papers/42776293PubMed
42750945Pulsed electromagnetic fields induce ferroptosis in osteosarcoma cells and promote osteogenic differentiation.J Bone Oncol2026https://conductscience.org/library/papers/42750945PubMed
42471540Mitochondrial Communication Networks in the Bone Microenvironment: From the Maintenance of Homeostasis to Translational Interventions for Bone Diseases.Stem Cell Rev Rep2026https://conductscience.org/library/papers/42471540PubMed
42232184Natural products in treating sepsis-associated lung and liver injuries by mediating ferroptosis, current progress, and future perspective.Front Pharmacol2026https://conductscience.org/library/papers/42232184PubMed
41938712Crosstalk between autophagy and ferroptosis in diabetes.Genes Dis2026https://conductscience.org/library/papers/41938712PubMed
41625218Spin Relaxation Does Not Preclude Magnetic Field Effects on Lipid Autoxidation.ACS Cent Sci2026https://conductscience.org/library/papers/41625218PubMed
41088176The multiplex crosstalk between non-coding RNAs, programmed cell death and related mechanisms: a dynamic duo in hematological malignancies.Cancer Cell Int2025https://conductscience.org/library/papers/41088176PubMed
41019823Enhanced Hydrophilicity and Antifouling Performance of PEG with Sulfoxide-Containing Side Chains for Nanomedicine Applications.Polym Sci Technol2025https://conductscience.org/library/papers/41019823PubMed
40892292Huangqi Guizhi Wuwu Decoction inhibits ferroptosis to improve cyclophosphamide induced immunosuppression through regulation of arachidonic acid metabolism.J Mol Histol2025https://conductscience.org/library/papers/40892292PubMed
40439806Mechanism and role of ferroptosis in the development of gastric cancer.Clin Exp Med2025https://conductscience.org/library/papers/40439806PubMed
40311754Electromagnetic fields regulate iron metabolism: From mechanisms to applications.J Adv Res2026https://conductscience.org/library/papers/40311754PubMed
40192984A causal inference study exploring the impact of iron status on the risk of thyroid cancer based on two-sample mendelian randomization.Discov Oncol2025https://conductscience.org/library/papers/40192984PubMed
40115032Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity.J Transl Int Med2025https://conductscience.org/library/papers/40115032PubMed
40098803Inhibitory Effects of Paclitaxel-Loaded Iron Oxide Nanoparticles on Non-Small Cell Lung Cancer by Enhancing Autophagy-Dependent Ferroptosis and Apoptosis Pathways.Cancer Manag Res2025https://conductscience.org/library/papers/40098803PubMed
40018650Application of Nanomaterials in Early Imaging and Advanced Treatment of Atherosclerosis.Chem Biomed Imaging2025https://conductscience.org/library/papers/40018650PubMed
39411064Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives.Front Pharmacol2024https://conductscience.org/library/papers/39411064PubMed
39380574Exploring the Use of Intracellular Chelation and Non-Iron Metals to Program Ferroptosis for Anticancer Application.Inorganics (Basel)2024https://conductscience.org/library/papers/39380574PubMed

See all 79 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30416846

GET https://conductscience.org/api/papers/v1/30416846/references?page=2